Company: NCEL
Filing Date: 2025-06-09
Form Type: F-4/A
Source: 0001213900-25-052354
Chunk: 476

Company: NewcelX Ltd.
Filing Date: 2025-06-09
Form: F-4/A
Chunk 476
---
,169 NLS Common Shares, (ii) 3,176 NLS Common Shares issuable upon exercise of options vested and exercisable within 60 days of May 28, 2025, (iii) 13,054 NLS Common Shares issuable upon exercise of common warrants exercisable within 60 days of May 28, 2025, (iv) 100,807 NLS Common Shares issuable upon exercise of common warrants exercisable within 60 days of May 28, 2025, subject to a beneficial ownership limitation of 9.99%, and (v) 1,925 NLS Common Shares issuable upon exercise of pre -fundedwarrants exercisable within 60 days of May 28, 2025, subject to a beneficial ownership limitation of 4.99%. The beneficial ownership limitation restricts from exercising that portion of the warrants that would result in Mr. Ronald Hafner owning, after exercise, a number of NLS Common Shares in excess of the beneficial ownership limitation. Mr. Hafner is Chairman of NLS Pharmaceutics Ltd. (4)Consists of (i) 1,339,686 NLS Common Shares, (ii) 384,970 Common Shares issuable upon vesting of RSUs and exercisable within 60 days of May 28, 2025, and (iii) 340,394 NLS Common Shares issuable upon exercise of options vested and exercisable within 60 days of May 28, 2025. (5)Consists of 1,588 NLS Common Shares issuable upon exercise of options within 60 days of May 28, 2025. (6)Consists of (i) 939 NLS Common Shares. (7)Consists of an aggregate of (i) 48,528 NLS Common Shares, and (ii) 2,541 NLS Common Shares issuable upon exercise of options within 60 days of May 28, 2025. (8)Consists of (i) 6,649,868 NLS Common Shares, and (ii) 207,913 NLS Common Shares issuable upon exercise of common warrants exercisable within 60 days of May 28, 2025, subject to a beneficial ownership limitation of 9.99%. The beneficial ownership limitation restricts from exercising that portion of the warrants that would result in League Jinn Sarl owning, after exercise, a number of